Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artesunate and Curcumin in Crohn's Disease
NCT04713631Phase 2Unknown
- Sponsor
- Sanjay Gandhi Postgraduate Institute of Medical Sciences
- Start
- Jan 2021
- Primary completion
- Dec 2023
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of artesunate, curcumin in Crohn's disease, sponsored by Sanjay Gandhi Postgraduate Institute of Medical Sciences. Status: unknown.
02
Drugs
artesunatecurcumin
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT04713631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04713631.